Table 3. Biopolymer-Based Nanocarrier Targeting Tumor/Cancer Cell Lines.
| Nanocarrier | Dimension | Drug moieties | Studies | Cancer cell | References |
|---|---|---|---|---|---|
| Propyl starch | 229 nm | Docetaxel | In vitro | Colon cancer | (150) |
| Amine functionalized polyacrylamide | 39.4–46.3 nm | Photosensitized drug (Photofrin conjugated) | In vivo | Breast cancer | (154) |
| RGD peptide (arginine-glycine-aspartic acid) conjugated triblock polymer | 99.8 ± 17.9 nm | Camptothecin | In vitro/in vivo | Brain cancer/glioma | (174) |
| Amine modified layered double hydroxide | NIR optical contrast agent, Indocyanine green | In vitro/in vivo | Colon cancer | (187) | |
| Chitosan | 9.4–23.4 nm | Quantum dots | In vitro | Non-Hodgkin lymphoma cancer cells | (198) |
| PEG functionalized melanin nanoparticles | 7.5 nm | Image contrast agents | In vivo | Hepatocellular carcinoma | (205) |